193 related articles for article (PubMed ID: 36244653)
1. Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial.
Voorrips SN; Boorsma EM; Beusekamp JC; DE-Boer RA; Connelly MA; Dullaart RPF; VAN-DER-Meer P; VAN-Veldhuisen DJ; Voors AA; Damman K; Westenbrink BD
J Card Fail; 2023 Jan; 29(1):33-41. PubMed ID: 36244653
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF).
Damman K; Beusekamp JC; Boorsma EM; Swart HP; Smilde TDJ; Elvan A; van Eck JWM; Heerspink HJL; Voors AA
Eur J Heart Fail; 2020 Apr; 22(4):713-722. PubMed ID: 31912605
[TBL] [Abstract][Full Text] [Related]
3. Ketone bodies in milk and blood of dairy cows: relationship between concentrations and utilization for detection of subclinical ketosis.
Enjalbert F; Nicot MC; Bayourthe C; Moncoulon R
J Dairy Sci; 2001 Mar; 84(3):583-9. PubMed ID: 11286410
[TBL] [Abstract][Full Text] [Related]
4. Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure.
Pietschner R; Kolwelter J; Bosch A; Striepe K; Jung S; Kannenkeril D; Ott C; Schiffer M; Achenbach S; Schmieder RE
Cardiovasc Diabetol; 2021 Nov; 20(1):219. PubMed ID: 34753480
[TBL] [Abstract][Full Text] [Related]
5. Breath acetone is a reliable indicator of ketosis in adults consuming ketogenic meals.
Musa-Veloso K; Likhodii SS; Cunnane SC
Am J Clin Nutr; 2002 Jul; 76(1):65-70. PubMed ID: 12081817
[TBL] [Abstract][Full Text] [Related]
6. Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
Nishimura R; Tanaka Y; Koiwai K; Ishida K; Salsali A; Kaspers S; Kohler S; Lund SS
Adv Ther; 2019 Oct; 36(10):2769-2782. PubMed ID: 31444706
[TBL] [Abstract][Full Text] [Related]
7. Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.
de Koning MLY; Westenbrink BD; Assa S; Garcia E; Connelly MA; van Veldhuisen DJ; Dullaart RPF; Lipsic E; van der Harst P
J Am Coll Cardiol; 2021 Oct; 78(14):1421-1432. PubMed ID: 34593124
[TBL] [Abstract][Full Text] [Related]
8. Ketones and the Heart: Metabolic Principles and Therapeutic Implications.
Matsuura TR; Puchalska P; Crawford PA; Kelly DP
Circ Res; 2023 Mar; 132(7):882-898. PubMed ID: 36996176
[TBL] [Abstract][Full Text] [Related]
9. Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses.
Owen OE; Reichard GA; Markus H; Boden G; Mozzoli MA; Shuman CR
J Clin Invest; 1973 Oct; 52(10):2606-16. PubMed ID: 4729054
[TBL] [Abstract][Full Text] [Related]
10. Effect of aldehyde dehydrogenase and alcohol dehydrogenase inhibitors and ethanol on blood and liver ketone bodies in the rat.
Pronko P; Zimatkin S; Kuzmich A
Pol J Pharmacol; 1994; 46(5):445-9. PubMed ID: 7894532
[TBL] [Abstract][Full Text] [Related]
11. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
12. Heart failure ketosis.
Lommi J; Koskinen P; Näveri H; Härkönen M; Kupari M
J Intern Med; 1997 Sep; 242(3):231-8. PubMed ID: 9350168
[TBL] [Abstract][Full Text] [Related]
13. Intra- and inter-subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co-transporter 2 inhibitor canagliflozin.
Polidori D; Iijima H; Goda M; Maruyama N; Inagaki N; Crawford PA
Diabetes Obes Metab; 2018 May; 20(5):1321-1326. PubMed ID: 29341404
[TBL] [Abstract][Full Text] [Related]
14. Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure.
Martens P; Dupont M; Verbrugge FH; Damman K; Degryse N; Nijst P; Reynders C; Penders J; Tang WHW; Testani J; Mullens W
JACC Heart Fail; 2019 May; 7(5):404-414. PubMed ID: 31047021
[TBL] [Abstract][Full Text] [Related]
15. Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure.
Nambu H; Takada S; Fukushima A; Matsumoto J; Kakutani N; Maekawa S; Shirakawa R; Nakano I; Furihata T; Katayama T; Yamanashi K; Obata Y; Saito A; Yokota T; Kinugawa S
Eur J Pharmacol; 2020 Jan; 866():172810. PubMed ID: 31738936
[TBL] [Abstract][Full Text] [Related]
16. Fasting Plasma Ketone Bodies Are Associated with NT-proBNP: A Potential Mechanism to Provide Fuel for the Failing Heart.
Palm CL; Shalaurova I; Connelly MA; Bakker SJL; Westenbrink BD; Dullaart RPF
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541768
[No Abstract] [Full Text] [Related]
17. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial.
Nassif ME; Qintar M; Windsor SL; Jermyn R; Shavelle DM; Tang F; Lamba S; Bhatt K; Brush J; Civitello A; Gordon R; Jonsson O; Lampert B; Pelzel J; Kosiborod MN
Circulation; 2021 Apr; 143(17):1673-1686. PubMed ID: 33550815
[TBL] [Abstract][Full Text] [Related]
18. Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders.
Spigoni V; Cinquegrani G; Iannozzi NT; Frigeri G; Maggiolo G; Maggi M; Parello V; Dei Cas A
Front Endocrinol (Lausanne); 2022; 13():972890. PubMed ID: 36339405
[TBL] [Abstract][Full Text] [Related]
19. Ketone body modulation of ligand-gated ion channels.
Pflanz NC; Daszkowski AW; James KA; Mihic SJ
Neuropharmacology; 2019 Apr; 148():21-30. PubMed ID: 30562540
[TBL] [Abstract][Full Text] [Related]
20. In vitro effect of ketones and hyperglycemia on feline hemoglobin oxidation and D- and L-lactate production.
Fallin CW; Christopher MM
Am J Vet Res; 1996 Apr; 57(4):463-7. PubMed ID: 8712507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
